Condition: Colorectal Cancer · Sponsor: Firalis SA
The primary goal is to develop easy accessible diagnostic tools for high risk subjects for colon cancer in different European populations to improve early CRC detection. These CRC screening technologies would be low cost, breakthrough and of high sensitivity and specificity.
This description comes directly from the study's public registry record.
Federica ZILLI, PhD · +33 (0) 389911320 · federica.zilli@firalis.com
Céline Meyer · celine.meyer@firalis.com
Always discuss trial participation with your own doctor first.
| Military Medical Academy Sofia, Gastroenterology Clinic, 3 Sveti Georgi Sofiiski str., Sofia 1606, Bulgaria | Sofia, Bulgaria | Recruiting |
| University Specialised Hospital for Active Treatment of Oncology Departement of Gastroenterology. | Sofia, Bulgaria | Not Yet Recruiting |
| UFC: Université de Franche-Comté Oncology department CHU Besançon | Besançon, France | Not Yet Recruiting |
| MKI UKSH Lübeck | Lübeck, Germany | Recruiting |
| UMC Mainz: University Medical Center Mainz | Mainz-GE, Germany | Recruiting |
| LSMU: Lithuanian University of Health Sciences Gastroenterology Department, | Kaunas, Lithuania | Recruiting |
| IPO: Instituto Português de Oncologia | Porto, Portugal | Recruiting |
| IBO: Institutul Oncologic Prof. Dr. Alexandru Trestioreanu București | Bucharest, Romania | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06515821